Jane Fleming

594 total citations
30 papers, 348 citations indexed

About

Jane Fleming is a scholar working on Genetics, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jane Fleming has authored 30 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 8 papers in Neurology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jane Fleming's work include Neurofibromatosis and Schwannoma Cases (8 papers), BRCA gene mutations in cancer (5 papers) and Prenatal Screening and Diagnostics (5 papers). Jane Fleming is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (8 papers), BRCA gene mutations in cancer (5 papers) and Prenatal Screening and Diagnostics (5 papers). Jane Fleming collaborates with scholars based in Australia, United Kingdom and United States. Jane Fleming's co-authors include Samantha L. Ginn, Ian E. Alexander, Karen J. Moore, S.D.M. Brown, Martyn Goulding, Rudi Balling, S. Sterrer, Karen P. Steel, Joseph H. Nadeau and Peter B. Rowe and has published in prestigious journals such as Journal of Investigative Dermatology, Genomics and Human Gene Therapy.

In The Last Decade

Jane Fleming

29 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Fleming Australia 9 184 111 57 36 29 30 348
Fabiana Guizzardi Italy 16 210 1.1× 153 1.4× 28 0.5× 24 0.7× 28 1.0× 26 523
Weiyi Mu United States 10 141 0.8× 148 1.3× 19 0.3× 25 0.7× 35 1.2× 28 346
Sandra E. Staffieri Australia 16 235 1.3× 95 0.9× 23 0.4× 119 3.3× 22 0.8× 43 567
Aamira Huq Australia 9 210 1.1× 98 0.9× 116 2.0× 20 0.6× 14 0.5× 20 345
Andrew T. Timberlake United States 12 183 1.0× 235 2.1× 41 0.7× 21 0.6× 35 1.2× 35 492
Ewa Jamroz Poland 13 241 1.3× 139 1.3× 50 0.9× 39 1.1× 83 2.9× 52 529
Maria Varela United States 12 170 0.9× 112 1.0× 37 0.6× 33 0.9× 109 3.8× 19 421
Alexandra T.M. Hendrickx Netherlands 13 478 2.6× 69 0.6× 38 0.7× 32 0.9× 34 1.2× 18 555
Joseph Bursztyn France 8 79 0.4× 72 0.6× 46 0.8× 21 0.6× 63 2.2× 20 250
Sharan Goobie Canada 15 162 0.9× 281 2.5× 55 1.0× 77 2.1× 52 1.8× 29 504

Countries citing papers authored by Jane Fleming

Since Specialization
Citations

This map shows the geographic impact of Jane Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Fleming more than expected).

Fields of papers citing papers by Jane Fleming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Fleming. The network helps show where Jane Fleming may publish in the future.

Co-authorship network of co-authors of Jane Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Fleming. A scholar is included among the top collaborators of Jane Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Fleming. Jane Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleming, Jane, Ashley Crook, Katrina Moore, et al.. (2025). The development and evaluation of educational resources for young women with neurofibromatosis type 1 undergoing breast cancer surveillance. Women s Health. 21. 922747806–922747806.
2.
Fleming, Jane, et al.. (2024). The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1. The Journal of Dermatology. 51(8). 1050–1059. 2 indexed citations
3.
Fleming, Jane, K. Moore, Ashley Crook, et al.. (2023). Clinical and imaging modality factors impacting radiological interpretation of breast screening in young women with neurofibromatosis type 1. Familial Cancer. 22(4). 499–511. 1 indexed citations
4.
Blakeley, Jaishri O., Ina Ly, Yemima Berman, et al.. (2023). Current and Emerging Imaging Techniques for Neurofibromatosis Type 1–Associated Cutaneous Neurofibromas. Journal of Investigative Dermatology. 143(8). 1397–1405. 6 indexed citations
5.
Fleming, Jane, et al.. (2023). “We are not a typical family anymore”: Exploring the experiences and support needs of fathers of children with Fragile X syndrome in Australia. American Journal of Medical Genetics Part A. 194(4). e63470–e63470. 1 indexed citations
6.
Gleeson, Margaret, Bettina Meiser, Rosie O’Shea, et al.. (2023). Exploring the impact of the reclassification of a hereditary cancer syndrome gene variant: emerging themes from a qualitative study. Journal of Community Genetics. 14(3). 307–317. 5 indexed citations
7.
Fleming, Jane, Kristine Barlow‐Stewart, Sondhya Ghedia, et al.. (2023). Expanding the Australian Newborn Blood Spot Screening Program using genomic sequencing: do we want it and are we ready?. European Journal of Human Genetics. 31(6). 703–711. 19 indexed citations
8.
Fleming, Jane, et al.. (2022). Characterization of health concerns in people with neurofibromatosis type 1. Molecular Genetics & Genomic Medicine. 11(1). 8 indexed citations
9.
10.
Barlow‐Stewart, Kristine, Jane Fleming, Yemima Berman, et al.. (2021). Evaluating the model of offering expanded genetic carrier screening to high school students within the Sydney Jewish community. Journal of Community Genetics. 13(1). 121–131. 1 indexed citations
11.
Verrall, Charlotte E., et al.. (2020). “Why and how did this happen?”: development and evaluation of an information resource for parents of children with CHD. Cardiology in the Young. 30(3). 346–352. 4 indexed citations
12.
Barlow‐Stewart, Kristine, et al.. (2020). Disclosure to genetic relatives without consent – Australian genetic professionals’ awareness of the health privacy law. BMC Medical Ethics. 21(1). 13–13. 13 indexed citations
13.
Fleming, Jane, Bronwyn Terrill, Marie Dziadek, et al.. (2019). Personal genomic screening: How best to facilitate preparedness of future clients. European Journal of Medical Genetics. 62(5). 397–404. 3 indexed citations
14.
Ginn, Samantha L., Jane Fleming, Peter B. Rowe, & Ian E. Alexander. (2003). Promoter Interference Mediated by the U3 Region in Early-Generation HIV-1–Derived Lentivirus Vectors Can Influence Detection of Transgene Expression in a Cell-Type and Species-Specific Manner. Human Gene Therapy. 14(12). 1127–1137. 31 indexed citations
15.
Fleming, Jane, Samantha L. Ginn, Ron P. Weinberger, et al.. (2001). Adeno-Associated Virus and Lentivirus Vectors Mediate Efficient and Sustained Transduction of Cultured Mouse and Human Dorsal Root Ganglia Sensory Neurons. Human Gene Therapy. 12(1). 77–86. 52 indexed citations
16.
Fleming, Jane, et al.. (1999). Genetic mapping of the whirler mutation. Mammalian Genome. 10(5). 513–519. 20 indexed citations
17.
Goulding, Martyn, S. Sterrer, Jane Fleming, et al.. (1993). Analysis of the Pax-3 Gene in the Mouse Mutant Splotch. Genomics. 17(2). 355–363. 105 indexed citations
18.
Clemmons, Roger M., et al.. (1986). Interaction between canine platelets and adult heartworms: Platelet recognition of heartworm surfaces. American Journal of Veterinary Research. 47(2). 322–325. 5 indexed citations
19.
Chaganti, R.S.K., L.R. Weitkamp, Jane Fleming, Glenn A. Miller, & J German. (1975). Polymorphic chromosomes and gene assignment in man. Cytogenetic and Genome Research. 14(3-6). 263–268. 7 indexed citations
20.
Fleming, Jane. (1962). Out-patient surgical treatment for basal-cell carcinomas. British Journal of Plastic Surgery. 15. 33–36. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabiana Guizzardi Breakdown of academic impact, for papers by Weiyi Mu Breakdown of academic impact, for papers by Sandra E. Staffieri Breakdown of academic impact, for papers by Aamira Huq Breakdown of academic impact, for papers by Andrew T. Timberlake Breakdown of academic impact, for papers by Ewa Jamroz Breakdown of academic impact, for papers by Maria Varela Breakdown of academic impact, for papers by Alexandra T.M. Hendrickx Breakdown of academic impact, for papers by Joseph Bursztyn Breakdown of academic impact, for papers by Sharan Goobie
Rankless by CCL
2026